首页> 外国专利> LSR RECEPTOR, ITS ACTIVITY, ITS CLONING, AND ITS APPLICATIONS TO THE DIAGNOSIS, PREVENTION AND/OR TREATMENT OF OBESITY AND RELATED RISKS OR COMPLICATIONS

LSR RECEPTOR, ITS ACTIVITY, ITS CLONING, AND ITS APPLICATIONS TO THE DIAGNOSIS, PREVENTION AND/OR TREATMENT OF OBESITY AND RELATED RISKS OR COMPLICATIONS

机译:LSR受体,其活性,克隆及其在肥胖,相关风险或并发症的诊断,预防和/或治疗中的应用

摘要

The present invention relates to a new complex receptor polypeptide LSR (Lipolysis Stimulated Receptor), characterized by its functional activities, the cloning of the cDNAs complementary to the messenger RNAs encoding each of the subunits of the multimeric complex, vectors and transformed cells, methods of diagnosis and of selection of compounds which can be used as medicament for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension, and more generally the various pathologies associated with abnormalities in the metabolism of cytokines.
机译:本发明涉及新的复合受体多肽LSR(脂解刺激受体),其特征在于其功能活性,克隆与编码多聚复合物的每个亚基的信使RNA互补的cDNA,载体和转化细胞,诊断和选择可用作预防和/或治疗病理和/或病原体,例如肥胖和厌食症,高脂血症,动脉粥样硬化,糖尿病,高血压的药物,以及更普遍地与疾病相关的各种病理的药物细胞因子的代谢。

著录项

  • 公开/公告号US2011165166A1

    专利类型

  • 公开/公告日2011-07-07

    原文格式PDF

  • 申请/专利号US201113020359

  • 申请日2011-02-03

  • 分类号A61K38/17;C07H21/04;C12N15/63;C07K14/705;C07K7/06;C07K7/08;A61K38/10;A61K31/7088;A61K35;C07K16/28;A61K39/395;A61P3/04;A61P3/06;A61P9/10;A61P3/10;A61P9/12;C12N5/10;C12N1;C12Q1/02;C12P21/02;

  • 国家 US

  • 入库时间 2022-08-21 18:11:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号